Navigation Links
NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
Date:2/27/2008

s thereafter. This pain is known as postherpetic neuralgia. PHN may occur in almost any area, but is especially common on the torso.

According to the Centers for Disease Control, there are approximately 1.0 million cases of shingles in the United States each year, and approximately one in five develop PHN. According to Jain BioPharma, in 2005 there were approximately 500,000 people in the United States living with PHN.

HIV-DSP is caused primarily by three factors: direct activation of cells known as sensory neurons by the HIV virus, the immune system's fight against the infection, and the drugs administered to treat HIV. Painful HIV-DSP is characterized by significant pain in the feet and hands.

According to Frost & Sullivan, neuropathic pain affects approximately 15% of the HIV infected community. According to the CDC, in 2005 there were 956,000 people in the United States infected with HIV. There are currently no specific treatments approved in the United States or Europe for HIV-DSP.

About NeurogesX, Inc.

NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on developing and commercializing novel pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including PHN, painful HIV- DSP and PDN. NeurogesX's late stage product portfolio is led by product candidate NGX-4010, a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions, that the company believes offers significant advantages over other pain therapies. Safe Harbor Statement

This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the "Act"). NeurogesX disclaims any intent or obligation to update these
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
2. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
3. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
4. EndoGastric Solutions(TM) Announces Results of EsophyX(TM) Multi-Center GERD Study
5. Dong-A PharmTech Co., Ltd. Announces Portal Hypertension Clinical Trial With Udenafil
6. MacuSight(TM) Announces Positive Preliminary Results From Phase 1 Study of Sirolimus in Wet Age-Related Macular Degeneration
7. InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131
8. amfAR Announces Funding for HIV Services and Research Aimed at Men Who Have Sex With Men in Developing Countries
9. ATS Medical Announces Initial Clinical Results of Stand-Alone Atrial Fibrillation Procedures Using ATS CryoMaze Product Line
10. ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R)
11. Accumetrics Announces $28.8 Million Financing and Initiation of Pivotal Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Research and Markets has announced the ... Diagnostic Tests, 9th Edition" report to their offering. ... clinical testing market and all of its segments, providing customers ... Companies For Business Planning. This is the ninth ... of 2013 and early 2014. New entrants, new technologies have ...
(Date:9/15/2014)... , Sept. 15, 2014  MedExpress Urgent Care, a national ... now offering flu shots for ages four and up at ... patients to get their flu shot early. ... the end of June, making late summer and early fall ... season. MedExpress Vice President of Provider and Clinical Quality, ...
(Date:9/15/2014)... CITY , Sept. 15, 2014 /PRNewswire-iReach/ -- ... invasive surgical (MIS) visualization products, is pleased to ... for its quality management system (QMS) through BSI, ... important step in Olive Medical complying with all ... devices.  It is the goal of Olive Medical ...
Breaking Medicine Technology:The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition 2The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition 3MedExpress Quotes Late Summer, Early Fall As Best Time to Receive Flu Shot 2Olive Medical Achieves ISO 13485:2003 Certification 2
... Assured Pharmacy (Pink Sheets: APHY ), a ... sufferers of chronic pain announced that total sales on a ... $1,422,163 which equates to $67,722 per business day .  This ... of $1,402,374 for June 2010 and an increase of 6.2 ...
... Novavax, Inc. (Nasdaq: NVAX ) President and CEO ... Health and Human Services Secretary Kathleen Sebelius and other public ... development of drugs and vaccines to prevent the spread of ... the plan,s five key initiatives: Define and ...
Cached Medicine Technology:Assured Pharmacy Reports Same Store Sales for the Month of July 2010 2Assured Pharmacy Reports Same Store Sales for the Month of July 2010 3NOVAVAX Endorses New U.S. Initiatives to Develop Medical Countermeasures 2NOVAVAX Endorses New U.S. Initiatives to Develop Medical Countermeasures 3
(Date:9/15/2014)... HealthDay Reporter MONDAY, Sept. ... twice as often as they,re actually needed for children ... More than 11 million antibiotic prescriptions written each ... to researchers from University of Washington and Seattle Children,s ... eradicate children,s viral illnesses, researchers said, but supports the ...
(Date:9/15/2014)... -- Births of multiple babies cost more and pose ... researchers report. The researchers suggest that limiting embryo ... ease some of that burden. Over the past ... births to older mothers and use of assisted reproductive ... South Wales, Australia. Their study, published online Sept. ...
(Date:9/15/2014)... PA (PRWEB) September 15, 2014 ... private insurance exchange technology, today announced that ... insurance organization in southeastern Pennsylvania, has selected the ... private health insurance exchange marketplace for employers with ... provided by Array Spectrum™, Independence will offer employer ...
(Date:9/15/2014)... New York (PRWEB) September 15, 2014 ... in U.S. courts, Bernstein Liebhard LLP notes that a ... be useful in curbing aggression in children with ADHD ... and parent training in behavioral management techniques. According to ... children with ADHD and aggression problems, half of whom ...
(Date:9/15/2014)... had a heart attack are at greater risk of death ... is missed, according to a new study. Researchers ... of their treatment early on, such as an electrocardiogram within ... steps in their care later on. The researchers added, however, ... all nine steps critical to their care are followed. , ...
Breaking Medicine News(10 mins):Health News:Kids Prescribed Antibiotics Twice as Often as Needed, Study Finds 2Health News:Kids Prescribed Antibiotics Twice as Often as Needed, Study Finds 3Health News:Study Ties Multiple Births to Higher Costs, Complications 2Health News:Study Ties Multiple Births to Higher Costs, Complications 3Health News:Independence Blue Cross Selects Array Spectrum™ Private Health Insurance Exchange Technology 2Health News:Independence Blue Cross Selects Array Spectrum™ Private Health Insurance Exchange Technology 3Health News:Risperdal News: Bernstein Liebhard LLP Notes New Study Regarding Risperdal and Children with ADHD 2Health News:Risperdal News: Bernstein Liebhard LLP Notes New Study Regarding Risperdal and Children with ADHD 3Health News:Risperdal News: Bernstein Liebhard LLP Notes New Study Regarding Risperdal and Children with ADHD 4Health News:Heart Attack Patients Face Greater Death Risk if Any Treatment Step Missed: Study 2
... Cogdell Spencer Inc. (NYSE: CSA ) announced ... shares of common stock. Cogdell Spencer also plans to ... additional 2,700,000 shares of common stock. Citi and KeyBanc ... Company intends to use the net proceeds from the offering ...
... China, May 26 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain,Drugstore ... or the "Company"), the largest,drugstore chain in China ... announced that the Company filed its annual report ... 2008 with the Securities and Exchange Commission on,May ...
... Planned Parenthood Federation of America is urging Gov. Arnold ... in family planning funds from the state budget. These ... at risk for countless women in California. "As a ... California, Planned Parenthood is on the frontline in ensuring ...
... over 77,000 Votes, St. Jude Children,s Research Hospital(R) Wins ... weeks, St. Jude Children,s Research Hospital(R) tallied 26.6% of ... first-ever Target giving campaign on Facebook(R). Bullseye Gives, ... 25, 2009, invited Facebook users to visit ...
... special needsBRADENTON, Fla., May 26 Animal-assisted & ... a new 9-acre facility that will use animatronic animal ... special needs. Headed by renowned dolphin-assisted therapy researcher ... to be the first of its kind in the ...
... Routine use in hospitalized patients should be re-evaluated, ... -- Instead of helping them get better faster, ... increases their risk of developing pneumonia while in ... ill hospital patients, the medications have been shown ...
Cached Medicine News:Health News:Cogdell Spencer Announces Commencement of Common Stock Offering 2Health News:Cogdell Spencer Announces Commencement of Common Stock Offering 3Health News:China Nepstar Chain Drugstore Filed 2008 Annual Report on Form 20-F 2Health News:Planned Parenthood Urges Gov. Schwarzenegger to Rescind Harmful Budget Cuts to Women's Health Care 2Health News:Planned Parenthood Urges Gov. Schwarzenegger to Rescind Harmful Budget Cuts to Women's Health Care 3Health News:More Than 167,000 Fans Flock to Target Facebook Page Helping Donate $3 Million to Ten Charities 2Health News:More Than 167,000 Fans Flock to Target Facebook Page Helping Donate $3 Million to Ten Charities 3Health News:More Than 167,000 Fans Flock to Target Facebook Page Helping Donate $3 Million to Ten Charities 4Health News:World's First Animatronic Animal Therapy Program Set to Open 2Health News:World's First Animatronic Animal Therapy Program Set to Open 3Health News:Acid-Suppressing Meds May Boost Pneumonia Risks 2Health News:Acid-Suppressing Meds May Boost Pneumonia Risks 3
Revised Drug calibrator that replaces existing Drug calibrator - this product contains Lithium in addition to Digoxin, Phenobarbital, OPhenytoin, & Theophulline....
... goal is to provide state-of-the-art rapid diagnostic ... Each year millions of people around the ... detection or undetected disease and illness. Diseases ... developing, manufacturing and marketing our tests to ...
Agglutination test on slide for qualitative and quantitative determination of Syphilis in serum or plasma....
... as a quality assurance reagent ... to Toxoplasma gondii (TOXO IgG), ... (rubella IgG), IgG antibody to ... antibody to herpes simplex virus ...
Medicine Products: